These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 19617306)
1. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization. Kaiser J; Thiesen J; Krämer I J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306 [TBL] [Abstract][Full Text] [Related]
2. Loading, release and stability of epirubicin-loaded drug-eluting beads. Spindeldreier KC; Thiesen J; Krämer I J Oncol Pharm Pract; 2016 Aug; 22(4):591-8. PubMed ID: 26160072 [TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment. Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955 [TBL] [Abstract][Full Text] [Related]
4. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. Sarakbi I; Krämer I J Oncol Pharm Pract; 2016 Dec; 22(6):749-756. PubMed ID: 26428284 [TBL] [Abstract][Full Text] [Related]
5. Compatibility of irinotecan-loaded DC Bead with different volumes and types of non-ionic contrast media. Sarakbi I; Thiesen J; Krämer I Eur J Hosp Pharm; 2016 Jan; 23(1):38-43. PubMed ID: 31156812 [TBL] [Abstract][Full Text] [Related]
6. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. Lewis AL; Gonzalez MV; Lloyd AW; Hall B; Tang Y; Willis SL; Leppard SW; Wolfenden LC; Palmer RR; Stratford PW J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):335-42. PubMed ID: 16517780 [TBL] [Abstract][Full Text] [Related]
7. An in-vitro evaluation of three types of drug-eluting microspheres loaded with irinotecan. Pereira PL; Plotkin S; Yu R; Sutter A; Wu Y; Sommer CM; Cruise GM Anticancer Drugs; 2016 Oct; 27(9):873-8. PubMed ID: 27416270 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. Jordan O; Denys A; De Baere T; Boulens N; Doelker E J Vasc Interv Radiol; 2010 Jul; 21(7):1084-90. PubMed ID: 20610183 [TBL] [Abstract][Full Text] [Related]
9. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Taylor RR; Tang Y; Gonzalez MV; Stratford PW; Lewis AL Eur J Pharm Sci; 2007 Jan; 30(1):7-14. PubMed ID: 17030118 [TBL] [Abstract][Full Text] [Related]
10. Loading profile of topotecan into polyvinyl alcohol microspheres (DC Bead™) over a 7-day period. Kaiser J; Krämer I J Oncol Pharm Pract; 2012 Jun; 18(2):222-8. PubMed ID: 22075006 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit. Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641 [TBL] [Abstract][Full Text] [Related]
12. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases. Tang Y; Czuczman PR; Chung ST; Lewis AL J Control Release; 2008 Apr; 127(1):70-8. PubMed ID: 18237814 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model. Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of ion exchange processes in drug-eluting embolization beads by use of an improved flow-through elution method. Swaine T; Tang Y; Garcia P; John J; Waters LJ; Lewis AL Eur J Pharm Sci; 2016 Oct; 93():351-9. PubMed ID: 27523788 [TBL] [Abstract][Full Text] [Related]
15. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer. Forster RE; Small SA; Tang Y; Heaysman CL; Lloyd AW; Macfarlane W; Phillips GJ; Antonijevic MD; Lewis AL J Mater Sci Mater Med; 2010 Sep; 21(9):2683-90. PubMed ID: 20563626 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the plasmatic and parenchymal elution kinetics of two different irinotecan-loaded drug-eluting embolics in a pig model. Gnutzmann DM; Mechel J; Schmitz A; Köhler K; Krone D; Bellemann N; Gockner TL; Mokry T; Kortes N; Sommer CM; Kauczor HU; Radeleff BA; Stampfl U J Vasc Interv Radiol; 2015 May; 26(5):746-54. PubMed ID: 25704223 [TBL] [Abstract][Full Text] [Related]
17. An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin. de Baere T; Plotkin S; Yu R; Sutter A; Wu Y; Cruise GM J Vasc Interv Radiol; 2016 Sep; 27(9):1425-1431. PubMed ID: 27402527 [TBL] [Abstract][Full Text] [Related]
18. An In Vitro Evaluation of Four Types of Drug-Eluting Embolics Loaded with Idarubicin. Guiu B; Hincapie G; Thompson L; Wu Y; Boulin M; Cassinotto C; Cruise GM J Vasc Interv Radiol; 2019 Aug; 30(8):1303-1309. PubMed ID: 31155500 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™. Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808 [TBL] [Abstract][Full Text] [Related]
20. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas PA; Kuzmission A; Ikeda K; Yasuo S Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]